Becton, Dickinson Shares Outstanding 2006-2018 | BDX

Current and historical number of shares outstanding for Becton, Dickinson (BDX) from 2006 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
Becton, Dickinson Annual Shares Outstanding
(Millions of US $)
2017 $224
2016 $218
2015 $208
2014 $198
2013 $199
2012 $209
2011 $226
2010 $240
2009 $247
2008 $253
2007 $255
2006 $257
2005 $261
Becton, Dickinson Quarterly Shares Outstanding
(Millions of US $)
Q3 2018 $274
Q2 2018 $267
Q1 2017 $230
Q4 2017 $224
Q3 2017 $221
Q2 2017 $218
Q1 2016 $218
Q4 2016 $218
Q3 2016 $217
Q2 2016 $217
Q1 2015 $216
Q4 2015 $208
Q3 2015 $215
Q2 2015 $200
Q1 2014 $197
Q4 2014 $198
Q3 2014 $197
Q2 2014 $197
Q1 2013 $198
Q4 2013 $199
Q3 2013 $199
Q2 2013 $198
Q1 2012 $200
Q4 2012 $209
Q3 2012 $205
Q2 2012 $210
Q1 2011 $218
Q4 2011 $226
Q3 2011 $224
Q2 2011 $225
Q1 2010 $233
Q4 2010 $240
Q3 2010 $238
Q2 2010 $241
Q1 2009 $243
Q4 2009 $247
Q3 2009 $246
Q2 2009 $246
Q1 2008 $248
Q4 2008 $253
Q3 2008 $252
Q2 2008 $253
Q1 2007 $253
Q4 2007 $255
Q3 2007 $254
Q2 2007 $255
Q1 2006 $255
Q4 2006 $257
Q3 2006 $255
Q2 2006 $258
Q1 2005 $256
Q4 2005 $261
Q3 2005 $260
Q2 2005 $262
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $66.712B $12.093B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
Align Technology (ALGN) United States $29.279B 78.06
McKesson (MCK) United States $24.600B 9.41
Laboratory Of America Holdings (LH) United States $18.300B 16.83
AmerisourceBergen (ABC) United States $17.737B 12.89
Cardinal Health (CAH) United States $15.037B 10.08
Cooper (COO) United States $12.436B 23.15
Henry Schein (HSIC) United States $11.846B 20.20
DENTSPLY SIRONA (XRAY) United States $8.676B 15.18
West Pharmaceutical Services (WST) United States $8.444B 43.66
Merit Medical Systems (MMSI) United States $2.997B 39.39
CONMED (CNMD) United States $2.148B 36.39
Patterson (PDCO) United States $2.134B 13.36
STAAR Surgical (STAA) United States $1.676B 235.00
Atrion (ATRI) United States $1.180B 34.99
Invacare (IVC) United States $0.555B 0.00
Antares Pharma (ATRS) United States $0.456B 0.00
Endologix (ELGX) United States $0.253B 0.00
Lifevantage (LFVN) United States $0.161B 33.32
Aceto (ACET) United States $0.097B 3.92
Pro-Dex (PDEX) United States $0.029B 12.89
Biolase (BIOL) United States $0.028B 0.00